Physician profile
Thomas Richard
NPI 1750315511
$2,526.91
in general payments reported to CMS, 2019-2025
34 companies · $259 in 2025
The $259 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $740 · 2020: $161 · 2021: $283 · 2022: $410 · 2023: $454 · 2024: $221 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $933.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $415.61 | 2020-2024 | |
| Pfizer INC. | $281.77 | 2019-2022 | |
| Shield Therapeutics INC | $272.81 | 2023-2025 | Accrufer |
| Amgen INC. | $268.08 | 2019-2021 | |
| Therapeuticsmd, INC. | $157.66 | 2019 | |
| Myriad Women'S Health, INC. | $116.51 | 2023 | Myrisk |
| Siemens Medical Solutions USA, INC. | $90.19 | 2022-2023 | Varian Cryocare Touch System |
| Organon LLC | $79.00 | 2024-2025 | Jada System, Nexplanon |
| Amag Pharmaceuticals, INC. | $76.04 | 2019-2020 | |
| Duchesnay USA Incorporated | $65.93 | 2019 | |
| Hologic Sales and Service, LLC | $55.98 | 2020-2023 | Aptima |
| Astellas Pharma US INC | $55.10 | 2023-2025 | Veozah |
| Scynexis, INC. | $53.18 | 2022 | |
| Avanos Medical | $52.43 | 2019-2023 | On-Q* Pump and Accessories |
| Convatec INC. | $48.55 | 2022-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $44.73 | 2019-2023 | Bd Onclarity |
| Radius Health, INC. | $39.27 | 2019 | |
| Mayne Pharma Commercial LLC | $35.66 | 2023 | |
| Sage Therapeutics, LLC | $34.29 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $34.12 | 2023-2025 | |
| Lupin INC. | $25.98 | 2020 | |
| Merck Sharp & Dohme LLC | $24.44 | 2019-2020 | |
| Dexcom, INC. | $23.69 | 2025 | Dexcom G6 Transmitter |
| Agile Therapeutics, INC. | $22.03 | 2022 | |
| Eisai INC. | $19.49 | 2025 | |
| Covidien Lp | $18.85 | 2019 | |
| Medtronic, INC. | $18.26 | 2024 | Ligasure |
| Axonics, INC. | $17.66 | 2023 | Axonics |
| Evofem Biosciences, INC. | $16.10 | 2022 | |
| Currax Pharmaceuticals LLC | $14.33 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.79 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.74 | 2023 | Seglentis |
| Cumberland Pharmaceuticals, INC. | $12.09 | 2020 | |
| Avion Pharmaceuticals | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Richard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.